Forensic Seized-Drug Analysis Standards
Forensic seized-drug analysis standards are concerned primarily with the analysis, sampling, and identification of seized-drugs. Serving to promote analysis that is consistent and reliable, forensic drug analysis standards cover the education and training of the forensic analysts involved, continuing on to delve further into the standard guides for microcrystal testing of cocaine, amphetamine, methamphetamine, phencyclidine (PCP), and its analogues. Additionally, forensic drug analysis standards address the underpinnings of other procedures, with the standard practice for validation of seized-drug analytical methods, as well as uncertainty assessments in the context of seized-drug analysis.
ASTM E2548-16
Standard Guide for Sampling Seized Drugs for Qualitative and Quantitative Analysis
1.1 This guide covers minimum considerations for sampling of seized drugs for qualitative and quantitative analysis. 1.2 This guide cannot replace knowledge, skill, or ability acquired through appropriate education, training, and experience and should be used in conjunction with sound professional judgment.
ASTM E2326-14
Standard Practice for Education and Training of Seized-Drug Analysts
1.1 This practice describes prerequisite formal education, training, and continuing professional development for those performing seized-drug analysis. It also describes the kinds of professional documents (for example, texts, manuals, or journals) that should be present in laboratories where analysis of seized drugs is conducted. 1.2 This practice does not replace knowledge, skill, ability, experience, education or training and should be used in conjunction with professional judgment. 1.3 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.
ASTM E2329-17
Standard Practice for Identification of Seized Drugs
1.1 This practice describes minimum criteria for the qualitative analysis (identification) of seized drugs. 1.2 Listed are a number of analytical techniques for the identification of seized drugs. These techniques are grouped on the basis of their discriminating power. Analytical schemes based on these groupings are described. 1.3 Additional information is found in Guides E1968 , E1969 , E2125 , and E2548 and Practices E2326 , E2327 , E2549 , and E2764 . 1.4 This standard should be used in conjunction with sound professional judgment, and cannot replace knowledge, skill, or ability acquired through appropriate education, training, and experience. 1.5 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety, health, and environmental practices and determine the applicability of regulatory limitations prior to use. 1.6 This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.
ASTM E1968-19
Standard Practice for Microcrystal Testing in Forensic Analysis for Cocaine
1.1 This practice describes procedures applicable to the analysis of cocaine using multiple microcrystal tests ( 1- 6 ) . 2 1.2 These procedures are applicable to cocaine, which is present in solid form or an injectable liquid form. They are not typically applicable to the analysis of cocaine in biological samples. 1.3 The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard. 1.4 These procedures could generate observations indicating a positive test for cocaine or its enantiomers which could be incorporated into the analytical scheme as defined by the laboratory. 1.5 This standard cannot replace knowledge, skills, or abilities acquired through appropriate education, training, and experience (see Practice E2326 ) and is to be used in conjunction with professional judgment by individuals with such discipline-specific knowledge, skills, and abilities. 1.6 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety, health, and environmental practices and determine the applicability of regulatory limitations prior to use. 1.7 This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.
ASTM E1969-19
Standard Practice for Microcrystal Testing in Forensic Analysis for Methamphetamine and Amphetamine
1.1 This practice describes procedures applicable to the analysis of methamphetamine and amphetamine using microcrystal tests ( 1- 6 ) . 2 1.2 These procedures are applicable to methamphetamine and amphetamine, which are present in solid dosage form or an injectable liquid form. These procedures are not typically applicable to the analysis of methamphetamine and amphetamine in biological samples. 1.3 The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard. 1.4 These procedures could generate observations indicating a positive test for methamphetamine or amphetamine which could be incorporated into the analytical scheme as defined by the laboratory. 1.5 This standard cannot replace knowledge, skills, or abilities acquired through appropriate education, training, and experience (see Practice E2326 ) and is to be used in conjunction with sound professional judgment by individuals with such discipline-specific knowledge, skills, and abilities. 1.6 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety, health, and environmental practices and determine the applicability of regulatory limitations prior to use. 1.7 This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.
ASTM E2125-19
Standard Practice for Microcrystal Testing in Forensic Analysis for Phencyclidine and Its Analogues
1.1 This practice describes procedures applicable to the analysis of phencyclidine and its analogues using microcrystal tests ( 1- 8 ) . 2 1.2 These procedures are applicable to phencyclidine and its analogues which are present in solid form or in a liquid form. They are not typically applicable to the analysis of phencyclidine and its analogues in biological samples. 1.3 The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard. 1.4 These procedures could generate observations indicating a positive test for phencyclidine and its analogues which could be incorporated into the analytical scheme as defined by the laboratory. 1.5 This standard cannot replace knowledge, skills, or abilities acquired through appropriate education, training, and experience (see Practice E2326 ) and is to be used in conjunction with sound professional judgment by individuals with such discipline-specific knowledge, skills, and abilities. 1.6 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety, health, and environmental practices and determine the applicability of regulatory limitations prior to use. 1.7 This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.
ASTM E2327-15e1
Standard Practice for Quality Assurance of Laboratories Performing Seized-Drug Analysis
1.1 This practice covers quality assurance issues in forensic laboratories performing seized-drug analysis including evidence handling, analytical procedures, report writing, method validation, documentation, proficiency testing, audits, and health and safety. 1.2 This practice is meant to apply only to qualitative seized-drug analysis. 1.3 This practice does not replace knowledge, skill, ability, experience, education, or training and should be used in conjunction with professional judgment. 1.4 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.
ASTM E2549-14
Standard Practice for Validation of Seized-Drug Analytical Methods
1.1 This practice addresses the validation of qualitative and quantitative seized-drug analytical methods. It discusses the validation of analytical methods in terms of their part in analytical schemes and in terms of performance characteristics including brief mention of measurement uncertainty and quality control parameters. 1.2 This practice does not replace knowledge, skill, ability, experience, education or training and should be used in conjunction with professional judgment. 1.3 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.
ASTM E2764-11
Standard Practice for Uncertainty Assessment in the Context of Seized-Drug Analysis
1.1 This practice provides guidance on the concept of uncertainty and its application to the qualitative and quantitative analysis of seized drugs. In this context, uncertainty encompasses limitations of qualitative methods as well as numerical ranges as applied to quantitative analyses. 1.2 The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard. 1.3 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.
